recombinant)

DRUG5 trials

Conditions

BronchiolitisInflammatory rheumatic diseaseRSV-infectionRespiratory Syncytial Virus (RSV)Respiratory syncytial virus infectionRespiratory tract infectionallogeneic - Hematopoietic Stem Cell Transplantation

Phase 2

A Phase II randomized trial of RSV vaccination in allogeneic hematopoietic stem cell transplant recipients (RSV-Allo study)

RecruitingCTIS2024-513290-53-00

Centre hospitalier universitaire de Liegeallogeneic - Hematopoietic Stem Cell Transplantation

Start: 2024-11-07Target: 204Updated: 2025-05-05

Phase 3

Prevention of RSV infection in infants by administering nirsevimab to infants, with or without maternal RSV vaccination: a randomised controlled trial in France as part of the Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)

Not yet recruitingCTIS2025-521755-23-00

Centre Hospitalier Annecy GenevoisBronchiolitis, Respiratory syncytial virus infection, Respiratory tract infection

Target: 2000Updated: 2025-10-21

Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)-RSV immunisation adaptive platform trial

Not yet recruitingCTIS2025-522194-11-00

Fondazione Penta EtsRespiratory Syncytial Virus (RSV)

Target: 400Updated: 2025-11-04

Phase 4

A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Abrysvo® for Preventing RSV Hospitalizations in Adults Aged 18 Years or Above (DAN-RSV)

RecruitingCTIS2024-516600-42-00

Gentofte Hospital, Pfizer Inc.RSV-infection

Start: 2024-11-18Target: 890000Updated: 2025-11-03

Vaccination against respiratory syncytial virus in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on the RSV immune response.

Not yet recruitingCTIS2024-518191-31-00

Region SkaneInflammatory rheumatic disease

Target: 180Updated: 2025-07-09

Related Papers

RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults